Related Experiment Video
Updated: Sep 16, 2025

07:55
An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA
Published on: February 17, 2023
4.1K
Enabling In-Silico Hit Discovery Workflows Targeting RNA with Small Molecules
Nikita Chopra1, Ara M Abramyan2, Zeineb Si Chaib3
1Schrödinger Inc, San Diego, California 92121, United States.
Journal of Chemical Information and Modeling
|July 8, 2025
Summary
This study enhances computational tools for predicting drug interactions with RNA targets. Improved accuracy in binding site and pose prediction aids structure-based drug discovery for ribonucleic acid (RNA) receptors.
Area of Science:
- Computational chemistry and structural biology.
- Drug discovery and medicinal chemistry.
- Molecular modeling and simulation.
Background:
- Ribonucleic acid (RNA) receptors are crucial targets in drug discovery.
- Accurate prediction of binding sites and ligand poses is essential for structure-based drug design.
- Existing computational methods require further refinement for RNA targets.
Purpose of the Study:
- To improve the performance of SiteMap and Glide for predicting RNA binding sites and ligand poses.
- To extend absolute binding free energy perturbation methods to RNA receptors.
- To validate computational predictions against experimental binding affinities.
Main Methods:
- Utilized and enhanced SiteMap and Glide algorithms for RNA receptor analysis.
- Applied absolute binding free energy perturbation calculations for RNA systems.
- Compared computational predictions with experimental binding affinity data.
Main Results:
- Achieved state-of-the-art or superior accuracy in predicting RNA binding sites and ligand poses.
- Demonstrated strong correlation between calculated and experimental binding affinities for RNA targets.
- Successfully adapted free energy perturbation methods for RNA receptor studies.
Conclusions:
- The enhanced computational methods provide reliable predictions for RNA-ligand interactions.
- These advancements facilitate structure-based drug discovery targeting RNA.
- The study offers a validated computational framework for RNA-focused drug development.
Related Concept Videos
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
RNA-seq
10.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.4K

